Thrombosis
Clinical
DOACs show safety benefit in early stages of CKD
In terms of efficacy and bleeding risk, what is known about anticoagulation in patients with chronically impaired renal function?
Clinical
A standardized approach to postop management of DOACs in AFib
Is it safe to adopt a standardized approach to direct oral anticoagulant (DOAC) interruption for patients with atrial fibrillation (AFib) who are...
News
In COVID-19 patients, risk of bleeding rivals risk of thromboembolism
News
A 4-point thrombocytopenia score was found able to rule out suspected HIT
News
NETs a possible therapeutic target for COVID-19 thrombosis?
News
COVID-19 anticoagulation trials ‘paused’ for futility, safety
The trials involved are the REMAP-CAP, ACTIV-4, and ATTACC studies.
Clinical
A multicenter trial of vena cava filters in severely injured patients
Can early (within 72 hours) prophylactic placement of inferior vena cava filter decrease the risk of pulmonary embolism or death in severely...
News
COVID-19 and risk of clotting: ‘Be proactive about prevention’
"We believe a systematic way of addressing this risk is best, with every patient hospitalized with COVID-19 receiving some type of...
News
Cost is the main hurdle to broad use of caplacizumab for TTP
“If we take finances out, I think almost every patient except those with a bleeding risk or bleeding problem should get it,” an investigator said...
News
What to do when anticoagulation fails cancer patients